Urru S A M, Masucci S, Baldo P, Gallo U, Schincariol P, Silimbani P, Vecchia S, Damuzzo V
Trento Provincial Authority for Health Services, Hospital Pharmacy Unit, Trento, Italy.
Azienda Ospedaliera Ordine Mauriziano Umberto I, Hospital Pharmacy Unit, Turin, Italy.
J Oncol Pharm Pract. 2025 Jun 26:10781552251351325. doi: 10.1177/10781552251351325.
IntroductionPharmacists are crucial in oncology and haematology, especially in medication management, patient counselling, and healthcare team collaboration. Their roles differ across institutions and countries. In Italy, where hospital pharmacies distribute oral cancer therapies, there is an emerging need for standardized counselling practices to enhance patient outcomes. This study aims to examine the current counselling practices of hospital pharmacists in Italy's oncology and haematology settings, identifying areas for improvement to better support patient care.MethodA web-based questionnaire was used for this prospective observational study, distributed through a national oncology pharmacists' network (Oncofarma). It was organized into three sections covering demographic information, counselling activities for patients and physicians, and communication methods. Data were analysed descriptively, with participants recruited through convenience sampling.ResultsOf the 99 participants from 61 centres surveyed, most were NHS hospital pharmacists. Half provided advice to oncologists or haematologists, and 36% engaged in direct patient counselling. Pharmacists typically advised on drug administration, side effects, and drug interactions, with communication primarily through face-to-face interactions or telephone calls. Counselling often took place at pharmacy counters or on hospital wards, with limited access to dedicated consultation spaces or times.ConclusionThe study reveals variability in Italian hospital pharmacists' counselling practices in oncology and haematology. Expanding patient counselling and introducing structured communication protocols may improve care quality. Standardised guidelines and training in communication, clinical knowledge and documentation could improve consistency, improve patient outcomes and support the integration of pharmacists into the healthcare team.
引言
药剂师在肿瘤学和血液学领域至关重要，尤其是在药物管理、患者咨询以及医疗团队协作方面。他们的角色在不同机构和国家存在差异。在意大利，医院药房负责分发口服癌症治疗药物，因此对标准化咨询实践的需求日益凸显，以改善患者治疗效果。本研究旨在考察意大利肿瘤学和血液学环境中医院药剂师当前的咨询实践情况，找出可改进之处，以便更好地支持患者护理。
方法
本前瞻性观察研究使用了基于网络的问卷，通过全国肿瘤药剂师网络（Oncofarma）进行分发。问卷分为三个部分，涵盖人口统计学信息、针对患者和医生的咨询活动以及沟通方式。数据采用描述性分析，参与者通过便利抽样招募。
结果
在接受调查的来自61个中心的99名参与者中，大多数是国民健康服务体系（NHS）医院的药剂师。一半的药剂师会为肿瘤学家或血液学家提供建议，36%的药剂师参与直接的患者咨询。药剂师通常就药物给药、副作用和药物相互作用提供建议，沟通主要通过面对面交流或电话进行。咨询通常在药房柜台或医院病房进行，使用专用咨询空间或时间的机会有限。
结论
该研究揭示了意大利医院药剂师在肿瘤学和血液学咨询实践中的差异。扩大患者咨询范围并引入结构化沟通方案可能会提高护理质量。在沟通、临床知识和文档记录方面的标准化指南和培训可以提高一致性，改善患者治疗效果，并支持药剂师融入医疗团队。
